Exploring the potential of hyperbaric oxygen therapy (HBOT) as an innovative treatment approach for psoriasis vulgaris through clinical evidence and mechanisms.
Explore how guselkumab, a targeted IL-23 inhibitor, is transforming treatment for moderate-to-severe plaque psoriasis through precision science and clinical evidence.